The association between non-melanoma skin cancer and a young dimorphic Alu element within the major histocompatibility complex class I genomic region

Tissue Antigens

Volumn 68, Issue 2, 2006, Pages 127-134

  Dunn, D S ^a   Inoko, H ^b   Kulski, J K ^a,b  

^a MURDOCH UNIVERSITY   (Australia)

^b TOKAI UNIVERSITY   (Japan)

Author keywords

Alu; Disease DNA markers; MHC; Polymorphism; Skin cancer

Indexed keywords

HLA A ANTIGEN; HLA C ANTIGEN; HLA F ANTIGEN; HLA G ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1;

ADULT; AGED; ALU SEQUENCE; ARTICLE; CANCER PATIENT; CANCER SUSCEPTIBILITY; CONTROLLED STUDY; DNA POLYMORPHISM; FEMALE; GENE CLUSTER; GENE FREQUENCY; GENE INSERTION; GENE LINKAGE DISEQUILIBRIUM; GENE LOCUS; GENE SEQUENCE; GENETIC HETEROGENEITY; GENETIC SUSCEPTIBILITY; GENOME ANALYSIS; GENOTYPE; HAPLOTYPE; HUMAN; INTRON; MAJOR CLINICAL STUDY; MALE; MICROSATELLITE MARKER; PRIORITY JOURNAL; SKIN CANCER; CASE CONTROL STUDY; GENE; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETICS; MIDDLE AGED; MOLECULAR GENETICS; POLYMERASE CHAIN REACTION; SKIN TUMOR;

AGED; ALU ELEMENTS; CASE-CONTROL STUDIES; FEMALE; GENE FREQUENCY; GENES, MHC CLASS I; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HAPLOTYPES; HLA-C ANTIGENS; HUMANS; LINKAGE DISEQUILIBRIUM; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; SKIN NEOPLASMS;

EID: 33747203506     PISSN: 00012815     EISSN: 13990039     Source Type: Journal    
DOI: 10.1111/j.1399-0039.2006.00631.x     Document Type: Article

References (41)

1. Preston DS, Stern RS. Nonmelanoma cancers of the skin. N Engl J Med 1992: 327: 1649-62.
2. Holme SA, Malinovsky K, Roberts DL. Malignant melanoma in South Wales: changing trends in presentation (1986-98). Clin Exp Dermatol 2001: 26: 484-9.
3. Giles GG, Marks R, Foley P. Incidence of nonmelanocytic skin cancer treated in Australia. Br Med J Clin Res Ed 1988: 29: 13-7.
4. Staples M, Marks R, Giles G. Trends in the incidence of nonmelanocytic skin cancer (NMSC) treated in Australia 1985-95: are primary prevention programs starting to have an effect? Int J Cancer 1998: 78: 144-8.
5. English DR, Kricker A, Heenan PJ, Randell PL, Winter MG, Armstrong BK. Incidence of non-melanocytic skin cancer in Geraldton, Western Australia. Int J Cancer 1997: 73: 629-33.
6. Chua MST, Veness MJ, Morgan G et al. Parotid lymph-node metastases from cutaneous squamous cell carcinomas: treatment outcomes and prognostic factors following surgery and adjuvant radiotherapy. Austral Radiol 2002: 46: 174-9.
7. Valery PC, Neale R, Williams G, Pandeya N, Siller G, Green A. The effect of skin examination surveys on the incidence of basal cell carcinoma in a Queensland community sample: a 10-year longitudinal study. J Invest Dermatol Symp Proc 2004: 9: 148-51.
8. Nolan RC, Chan MT, Heenan PJ. A clinicopathologic review of lethal nonmelanoma skin cancers in Western Australia. J Am Acad Dermatol 2005: 52: 101-8.
9. Lowes MA, Dunckley H, Watson N et al. Regression of melanoma, but not keratoacanthoma, is associated with increased HLA-B22 and decreased HLA-B27 and HLA-DR1. Melanoma Res 1999: 9: 539-44.
10. Cohen MM Jr. Nevoid basal cell carcinoma syndrome: molecular biology and new hypotheses. Int J Oral Maxillofac Surg 1999: 28: 216-23.
11. Armstrong BK, Kricker A. Skin cancer. Dermatol Clin 1995: 13: 583-94.
12. Marks R. Squamous cell carcinoma. Lancet 1996: 347: 735-8.
13. Streilein JW. Immunogenetics of sunlight induced skin cancer. Photochem Photobiol 1996: 63: 422-4.
14. Hussein MR. Ultraviolet radiation and skin cancer: molecular mechanisms. J Cutan Pathol 2005: 32: 191-205.
15. Bouwes Bavinck JN, Claas FH. The role of HLA molecules in the development of skin cancer. Hum Immunol 1994: 41: 173-9.
16. Urosevic M, Dummer R. HLA-G in skin cancer: a wolf in sheep's clothing? Hum Immunol 2003: 64: 1073-80.
17. Rodriguez T, Mendez R, Roberts CH et al. High frequency of homozygosity of the HLA region in melanoma cell lines reveals a pattern compatible with extensive loss of heterozygosity. Cancer Immunol Immunother 2005: 54: 141-8.
18. Cerimele D, Contu L, Carcassi C et al. HLA and multiple skin carcinomas. Dermatologica 1988: 176: 176-81.
19. Guillen FJ, Day CL Jr, Murphy GF. Expression of activation antigens by T cells infiltrating basal cell carcinomas. J Invest Dermatol 1985: 85: 203-6.
20. Rompel R, Petres J, Kaupert K, Muller-Eckhardt G. Human leukocyte antigens and multiple basal cell carcinomas. Recent Results Cancer Res 1995: 139: 297-302.
21. Emtestam L, Wallberg P, Aldener A, Olerup O. Multiple basal cell carcinomas: no association with HLA-DRB, HLA-DQA1 or HLA-DQB1 in Swedish patients. Br J Dermatol 1996: 134: 886-91.
22. Reifenberger J, Wolter M, Knobbe CB et al. Somatic mutations in the PTCH, SMOH, SUFUH and TP53 genes in sporadic basal cell carcinomas. Br J Dermatol 2005: 152: 43-51.
23. Oka A, Hayashi H, Tomizawa M et al. Localization of a non-melanoma skin cancer susceptibility region within the major histocompatibility complex by association analysis using microsatellite markers. Tissue Antigens 2003: 61: 203-10.
24. Batzer MA, Stoneking M, Alegria-Hartman M et al. African origin of human-specific polymorphic Alu insertions. Proc Natl Acad Sci USA 1994: 91: 12288-92.
25. Rowold DJ, Herrera RJ. Alu elements and the human genome. Genetica 2000: 108: 57-72.
26. Roy-Engel AM, Carroll ML, Vogel E et al. Alu insertion polymorphisms for the study of human genomic diversity. Genetics 2001: 61: 6640-8.
27. Martinez J, Dugaiczyk LJ, Zielinski R, Dugaiczyk A. Human genetic disorders, a phylogenetic perspective. J Mol Biol 2001: 308: 587-96.
28. Comas D, Plaza S, Calafell F, Sajantila A, Bertranpetit J. Recent insertion of an Alu element within a polymorphic human-specific Alu insertion. Mol Biol Evol 2001: 18: 85-8.
29. Kulski JK, Dunn DS. Polymorphic Alu insertions within the Major Histocompatibility Complex class I genomic region: a brief review. Cytogenet Genome Res 2005: 110: 193-202.
30. Dunn DS, Romphruk AV, Leelayuwat C, Bellgard M, Kulski JK. Polymorphic Alu insertions and their associations with MHC class I alleles and haplotypes in the northeastern Thais. Ann Hum Genet 2005: 69: 364-72.
31. Dunn DS, Inoko H, Kulski JK. Identification and characterisation of a dimorphic Alu located between the TFIIH and CDSN genes within the Major Histocompatibility Complex. Electrophoresis 2003: 24: 2740-8.
32. Schneider S, Roessli D, Excofier L. Arlequin: A Software for Population Genetics Data Analysis. Ver 2.000. Geneva: Genetics and Biometry Laboratory, Department of Anthropology, University of Geneva, 2000.
33. Perneger TV. What is wrong with Bonferroni adjustments. Br Med J 1998: 136: 1236-8.
34. Sankoh AJ, Huque MF, Dubey D. Some comments on frequently used multiple endpoint adjustment methods in clinical trials. Stat Med 1997: 16: 2529-42.
35. Oka A, Tamiya G, Tomizawa M et al. Association analysis using refined microsatellite markers localizes a susceptibility locus for psoriasis vulgaris within a 111 kb segment telomeric to the HLA-C gene. Hum Mol Genet 1999: 8: 2165-70.
36. Nair RP, Stuart P, Henseler T et al. Localization of psoriasis- susceptibility locus PSORS1 to a 60-kb interval telomeric to HLA-C. Am J Hum Genet 2000: 66: 1833-44.
37. Matsuzaka Y, Tounai K, Denda A et al. Identification of novel candidate genes in the diffuse panbronchiolitis critical region of the class I human MHC. Immunogenetics 2002: 54: 301-9.
38. Guerrin M, Simon M, Montezin M, Haftek M, Vincent C, Serre G. Expression cloning of human corneodesmosin proves its identity with the product of the S gene and allows improved characterization of its processing during keratinocyte differentiation. J Biol Chem 1998: 273: 22640-7.
39. Suomela S, Elomaa O, Asumalahti K et al. HCR, a candidate gene for psoriasis, is expressed differently in psoriasis and other hyperproliferative skin disorders and is downregulated by interferon-gamma in keratinocytes. J Invest Dermatol 2003: 121: 1360-4.
40. Sanchez F, Holm SJ, Mallbris L, O'Brien KP, Stahle M. STG does not associate with psoriasis in the Swedish population. Exp Dermatol 2004: 13: 413-8.
41. Shiina T, Inoko H, Kulski JK. An update of the HLA genomic region, locus information and disease associations: 2004. Tissue Antigens 2004: 64: 631-49.